Molecular Patterns of Extreme and Persistent Cholesterol Efflux Capacity

Area of Science:

• Cardiovascular Research
• Lipid Metabolism
• Biomarker Discovery

Background:

• Cholesterol efflux capacity (CEC) is a key cardiovascular biomarker, predicting atherosclerotic cardiovascular disease (ASCVD) events.
• CEC's modest association with HDL-C levels may explain therapeutic failures.
• Determinants of CEC variation remain poorly understood.

Purpose of the Study:

• To determine if extreme high and low CEC represent robust, persistent phenotypes.
• To characterize CEC associations with lipids, proteins, and phospholipids across lipoprotein particle sizes.

Main Methods:

• Utilized data from 2924 Dallas Heart Study participants (2000-2002).
• Prospectively recruited individuals with extreme CEC (bottom 10% and top 90%).
• Analyzed fraction-specific CEC using size exclusion chromatography on apolipoprotein B-depleted plasma.

Main Results:

• Extreme high and low CEC were confirmed as persistent phenotypes after 15 years.
• Significant differences in fraction-specific CEC patterns were observed between high and low efflux groups.
• Fraction-specific CEC correlated with phospholipids across particle sizes, but not with apolipoprotein A-I or cholesterol.

Conclusions:

• Extreme cholesterol efflux capacity is a stable and robust phenotype.
• CEC exhibits significant variation across lipoprotein particle size distribution.
• Further research is needed to identify specific molecular determinants of size-specific CEC.